307 related articles for article (PubMed ID: 15106079)
21. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy.
Ruëff F; Bilò MB; Jutel M; Mosbech H; Müller U; Przybilla B;
J Allergy Clin Immunol; 2009 Jan; 123(1):272-3; author reply 273. PubMed ID: 19130944
[No Abstract] [Full Text] [Related]
22. Diagnosis and treatment of allergy to hymenoptera venoms.
Hamilton RG
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
[TBL] [Abstract][Full Text] [Related]
23. The sting challenge test in Hymenoptera venom allergy: pros and cons.
Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
[TBL] [Abstract][Full Text] [Related]
24. [Advice and handy drugs can be sufficient in bee and wasp venom allergy].
Foucard T
Lakartidningen; 1991 Jun; 88(26-27):2365-6. PubMed ID: 1857153
[No Abstract] [Full Text] [Related]
25. [Desensitization of allergy to hymenoptera venoms].
Przybilla B; Ruëff F
Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
[TBL] [Abstract][Full Text] [Related]
26. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
27. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
28. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
[TBL] [Abstract][Full Text] [Related]
29. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
30. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
31. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
32. [Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study].
Tworek D; Bocheńska-Marciniak M; Kupczyk M; Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2006; 74(2):153-8. PubMed ID: 17269362
[TBL] [Abstract][Full Text] [Related]
33. Stinging insect allergy and venom immunotherapy.
Gupta P; Greenberger PA
Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
[No Abstract] [Full Text] [Related]
34. Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy.
Bożek A; Kołodziejczyk K
Hum Vaccin Immunother; 2018 Feb; 14(2):288-291. PubMed ID: 29106324
[TBL] [Abstract][Full Text] [Related]
35. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
[TBL] [Abstract][Full Text] [Related]
36. Venom immunotherapy: pitfalls and open questions.
Aberer W; Sturm G
Immunotherapy; 2011 Nov; 3(11):1277-9. PubMed ID: 22053877
[No Abstract] [Full Text] [Related]
37. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of maintenance bee venom immunotherapy administered at 6-month intervals.
Goldberg A; Confino-Cohen R
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):352-7. PubMed ID: 17941283
[TBL] [Abstract][Full Text] [Related]
39. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
40. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
Wüthrich B; Arrendal H; Lanner A
Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]